Lumbrokinase, extracted from the cultured earthworm of Eisenia fetida, has been widely 7 used as biochemical medicine in China to prevent or treat thrombosis. In the present study, the 8 mechanism of lumbrokinase was investigated using the fibrin plate method. The results 9 revealed that lumbrokinase contained both fibrinolytic and kinase components. The method of 10 fibrin-zymography was used to show the existence and activity of lumbrokinase, and we proved 11 that the fibrin-zymogram gel could be adopted as the identification method of earthworm.
China). Other chemicals were of analytical grades. 48 Enzymatic activity research 49 Sample preparation: For fibrin plate tests, the drugs from five manufacturers dissolved in 50 the 0.9% sodium chloride, and then they were diluted into a range of concentration 51 (2000U/mL,4000U/mL,6000U/mL,8000U/mL and 10000U/mL). The standard of lumbrokinase 52 was diluted to achieve the same concentration. 53 Preparation of fibrin plate: Fibrin plates were prepared using the standard method. [10] 54 39mL of the fibrinogen solution(1.5mg/mL, diluted with PBS buffer) was added into the 55 agarose solution(55℃) and mixed toughly. Subsequently, thrombin solution 3.0mL was added, 56 and the solution was transferred to the plastic culture plates. After evenly mixing the solution, 57 the solution stood still for 1 h at ambient temperature until it was solidified. The preparation of 58 fibrin and kinase plates was the same except that 1mLplasminogen solution (3U/mL) was added 59 into the plates. 60 For activity analysis, 10 µL test solution of different concentrations into the pole was 61 precisely measured, and then the plates were incubated at 37℃ for 18h. The diameter of the 62 hydrolyzed clear zone was measured, and the final values were an average of three replicates.
64
Fibrin-zymography 65 Lumbrokinase drug substances dissolved into 3mg/mL with the solution of 0.9% sodium 66 chloride. SDS-fibrin gel was prepared as described by Kim and Choi.[11, 12] The composition 67 of the gel(10%) is listed in Table 1 . 10µL of the supernatant from the drug substances which 68 was diluted in the sample loading buffer were loaded into the fibrin gel. After running the 69 gel(80V 30min;120V 60min), it was soaked in the 2.5% Triton-100 solution for 30min and then 70 incubated in the reaction buffer solution (0.05M KH 2 PO 4 ,0.04MNaOH;pH7.4) at 37℃ for 40 71 min. The gel was stained with Coomassie Brilliant blue for 2h and then distained. The digested 72 bands reflecting the enzymatic activities were visualized as clear bands of fibrinolysis against a 73 dark-blue background of undigested fibrin substrate.
74
Liquid chromatography and mass spectrometry 75 Enzyme digestion: A solution containing about 1 mg of lumbrokinase per 1 ml was diluted with 76 a solution containing 6 M urea, 50 mM Tris-HCl (pH 8.0) and 5 mM DTT, incubated for 20 77 min at 95℃, and then cooled to ambient temperature. Subsequently, a 6-fold volume of 50 mM 78 ammonium bicarbonate solution (pH 7.8) was added. Chymotrypsin (chymotrypsin: sample = 1: 79 200) was added and digested at 37°C for 12h, and then the solution was centrifugated(8000g) 80 for 30 min before loading the sample to the mass spectrometry. 81 82 LC-ESI-MS/MS analysis：An amount equivalent to 2µL of the digested peptide underwent 83 LC-MS/MS using a UPLC system and a Q-TOF mass spectrometry(Waters UPLC® G 2 S Q-TOF).
84
Mobile phase A was 0.1% formic acid, while mobile phase B was acetonitrile. The flow rate 85 was 0.3ml/min. The gradient elution program was allowed for 5min at 5%B, followed by a 86 40min step that raised eluent B to 40%, a 10 min washing at 40%, and equilibration at 5%B.
87
The total analysis time was 60min. For mass spectrometry, the parameters included: capillary The fibrin plate was used to ascertain the direct fibrinolytic activity of lumbrokinase, as 99 shown in Fig 1a. Besides, the fibrin-plasminogen plate was used to measure the fibrinolytic and 100 kinase activity of lumbrokinase, as shown in Fig 1b. The results revealed that the diameter of 101 the fibrin-plasminogen plate was significantly larger than that of the fibrin plate (Table 2) , 102 indicating that lumbrokinase not only exhibited the direct degradation activity of fibrin, but also 103 the ability of activating plasminogen to produce indirect fibrinolysis, showing a kinase activity.
104
The current quality specification only measured its direct fibrinolytic activity by calibration 105 curve and ignored the kinase activity. In our study, we observed that in the fibrin-plasminogen 106 plate, the tendency of diameters of hydrolyzed clear zone between the sample and the standard 107 was parallel, as shown in Fig 2. Furthermore, the parallel line method was employed to measure 108 the total activity of lumbrokinase. As shown in table 3, the total potency calculation of all the 109 five manufacturers 'products were consistent with the method requirements, and three 110 independent tests exhibited relatively good precision, suggesting that the parallel line method 111 could be used to effectively measure total potency of lumbrokinase. In the robustness test, as shown in Fig 4b and 4c , the effects of fibrinogen concentration 136 and incubation time on the clarity of fibrin-zymography were explored. The results showed that 137 when the fibrinogen concentration ranged from 0.25to1.0mg/ml, and the incubation time ranged 138 from 10 to 60 min. Accordingly, the fibrinolytic bands could be easy to identify.
139
In the test of range of quantitation, as shown in Fig 4d, a clear figure of fibrin-zymography 140 could be generate when lumbrokinase concentration ranged from 0.5 to 37.5ug.
141
Based on the validation results, the method of fibrin-zymography satisfied the validation 142 requirements, and it could be used as the identification method of Eisenia foetida. 143 Proteins identification in lumbrokinase drug substances by electrospray 144 ionization mass spectrometry(ESI-MS) 145 According to the results of fibrin plate experiments, lumbrokinase had two mechanisms of 146 lysing fibrin, and we confirmed the presence of fibrinolytic protein in lumbrokinase using 147 fibrin-zymography. Next, we identified the protein in lumbrokinase drug substances by LC-MS.
148
The drug substances were treated with chymotrypsin. As shown in Table 4 , fifteen fibrinolytic 149 activity-related components were identified, and no other proteases were identified. 8-9 150 fibrinolytic proteins in each manufacturer were detected. Fibrinolytic protease 1, fibrinolytic 151 protease P-III-1and protein ARSP1 existed in all products. The results of mass spectrometry 152 suggested that lumbrokinase drug substances contained fibrinolytic and kinase components, 153 which was consistent with the results of lumbrokinase activity measurement.
154
Subsequently, using the sequence alignment tool, the amino acid sequence of these proteins The fibrin-zymography confirmed the presence of active proteins in the lumbrokinase. The 170 results of fibrin plate revealed that lumbrokinase had dual action mechanisms, which was 171 further verified using the mass spectrometry. These results were consistent with the report that 172 the protein property of these proteases, by activating the plasminogen into plasmin, both had the 173 activity of degrading the fibrin directly and the activity of degrading the fibrin indirectly. [14] 174 However, the current fibrin plate method used in the potency determination of lumbrokinase 175 only measured its direct fibrinolytic activity with its kinase activity excluding. Accordingly, the 176 current method should be optimized to measure its total activity. Our study showed that it was 177 theoretically feasible to achieve the potency improvement of lumbrokinase using the parallel 178 method.
179
It was reported that lumbrokinase(LK) was a group of fibrinolytic isozymes with molecular 180 weights ranging from 25 to 32KD. [2, 24-26] These hydrolytic enzymes existed in different 181 earthworm species, including Lumbricus rubellus, [27, 28] Lumbricus bimastus [9] and Eisenia 182 fetida [29] [30] [31] . However, in the drug specification, identification of lumbrokinase based on the to optimal pH of pepsin. Given this, we found the phenomena of protein precipitation in the 195 process of treating lumbrokinase drug substances with pepsin. Thus, chymotrypsin was selected 196 as the treating enzyme since the restriction sites, phenylalanine, tyrosine, tryptophan were 197 widely distributed in lumbrokinase.
198
It is noteworthy that the database of Eisenia foetida contained very few types of proteins 199 due to the lack of related research. Most of the proteins were fibrinolytic related. Thus, the 200 results of mass spectrometry revealed that the drugs contained fibrinolytic proteins, and no 201 other proteins were identified. Accordingly, a further study is required with the gradual update 202 of the database.
203
Since the lumbrokinase was not isolated and purified from the earthworm in our study, 204 which proteins showed the fibrinolytic activity, which one showed the kinase activity and which 205 one showed both could not be concluded. However, our study laid a foundation for the 
